2024
|
Invention
|
Dual modulator of mglur5 and 5-ht2a receptor, and use thereof.
Disclosed are a dual modulator of... |
|
Invention
|
Double regulator for mglur5 and hdac6 and use thereof. Disclosed are a double regulator for mGluR... |
2023
|
Invention
|
Pharmaceutical composition containing high concentration of opiranserin. A pharmaceutical composi... |
|
Invention
|
Pharmaceutical composition for preventing or treating mental disorder. 2A2AR. |
2021
|
Invention
|
Dual modulator of mglur5 and 5-ht2a receptor, and use thereof. Disclosed are a dual modulator of ... |
|
Invention
|
Dual regulator for mglur5 and 5-ht2a receptors and use thereof. A dual regulator for MGLUR5 and 5... |
2020
|
Invention
|
Colonic purgative composition.
The present invention relates to a colonic purgative composition ... |
|
Invention
|
Colonic purgative composition. The present invention relates to a colonic purgative composition a... |
|
Invention
|
Method of preventing or treating postoperative pain.
A method for treating or preempting pain in... |
|
Invention
|
Method of preventing or treating postoperative pain. A method for treating or preempting pain inc... |
2019
|
P/S
|
Medicines for human purposes and veterinary preparations for the treatment of central nervous sys... |
2012
|
Invention
|
Benzamide derivative and use thereof. Disclosed are a novel benzamide derivative and pharmaceutic... |
|
Invention
|
Novel benzamide derivative and use thereof. The present invention relates to a novel benzamide de... |
|
Invention
|
Combination of effective substances causing synergistic effects of multiple targeting and use the... |
2008
|
Invention
|
The clinical testing method for neuropathic pain, and a measuring device thereof. Disclosed there... |
|
Invention
|
The measuring device of pain reaction for experimental animals. Disclosed therein is a system for... |